# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-04-02T00:13:42.118711

---

**Idea Fidelity**

The paper stays largely faithful to the manifest’s intent. It focuses on the staggered adoption of Differential Response (DR) and treats DR as a change in the administrative data-generating process rather than a true safety improvement. The main empirical strategy—Callaway and Sant’Anna’s staggered DiD—is implemented, and the decomposition of referrals/victims plus the fatality falsification are present. One notable omission is more explicit engagement with the manifest’s proposed falsifications (e.g., physical vs. neglect substantiations and placebo in non-adoption years) beyond the high-level references. Including those would have strengthened fidelity to the promised identification battery.

---

**Summary**

The paper argues that the national decline in substantiated child maltreatment victims largely reflects the reclassification of low-risk referrals through Differential Response (DR) rather than improvements in child safety. Using state-level NCANDS/ACF data for 2000–2014, it employs both TWFE and Callaway–Sant’Anna staggered DiD estimators to estimate the causal effect of DR adoption on victim rates and supplements this with referral-victim decompositions, maltreatment-type contrasts, and a fatality-based falsification.

---

**Essential Points**

1. **Power and Precision in the Main Estimate**  
   The core Callaway–Sant’Anna point estimate is both statistically imprecise and economically small relative to national trends. Given that the paper’s primary claim is that DR mechanically shifts victim counts, the current evidence is underpowered to pin down the magnitude of that shift. The authors should either expand the sample (e.g., include later years or more granular county-level data if possible) or supplement with alternative identification (see suggestions) that directly measures the diversion rate to family assessment. Without this, the key quantitative claim remains speculative.

2. **Validation of the Parallel Trends Assumption**  
   The restricted event study shows noisy pre-trends, with several coefficients large relative to their standard errors and missing standard errors at $t-1$. The paper should provide more systematic diagnostics: e.g., cover more pre-periods (perhaps using earlier data or synthetic controls) or present placebo adoption years, as promised in the manifest. A formal test like the pre-trend coefficient aggregation (or using SUN–AB event studies for all cohorts) would better support the identification.

3. **Mechanism Evidence within DR States**  
   The mechanism—diversion of referrals to the assessment track—relies on an assumption that DR changes reporting rather than referrals. Currently, the decomposition is purely descriptive and national in scope. The authors should show within-state evidence that the share of referrals classified as family assessment increases systematically post-DR and that these diverted referrals would previously have been tracked as investigations. Without such verification, the claim that DR is “manufacturing” the decline lacks direct empirical grounding.

---

**Suggestions**

- **Augment Data to Capture Measurement Boundaries**  
  Consider extending the panel beyond 2014 (up to 2023) if data are available; more years would improve power, capture later adopters, and allow examination of whether the victim–referral divergence persists. If NCANDS (via Kids Count) offers victim rate data up to 2023, incorporate those years even if the DR adoption data for some late adopters are less precise.

- **Leverage Administrative Variation in DR Intensity**  
  Not all states implement DR equally—some divert a small share of referrals while others divert a majority. If accessible, include measures of DR intensity (e.g., share of screened-in referrals assigned to family assessment) to explain variation in the estimated effect. Connecting the diversion share to measured victim declines would transform the exercise from a binary treatment to a continuous “dose” that directly tests the mechanism.

- **Strengthen the Fatality Falsification**  
  The fatality series is compelling, but national aggregates are weak proxies for state-level dynamics. If possible, conduct a state-level regression of fatality rates on DR adoption with state and year fixed effects. Even if noise is high, a zero effect across states would be more persuasive than a national time series. Moreover, consider checking other extreme outcomes (e.g., adoption of severe physical abuse cases) that should also be unaffected.

- **Clarify the Role of Referral Trends**  
  The referral–victim decomposition is useful, but it would help to analyze whether referral increases are concentrated in states before/after DR adoption. Is the referral growth uniform, or do adopting states experience particular patterns? Presenting parallel trends for referrals (with event studies) would reinforce the claim that the “input” didn’t decline, only the counted “output.”

- **Engage More Fully with Prior Literature on DR**  
  While several references are cited, the paper could better situate itself in the DR literature by discussing work that has measured re-reporting or case outcomes post-DR (e.g., Glisson et al.). Does the lack of a significant change in re-reports align with the idea that DR just changes counting? Explicitly framing the paper as complementary to those efforts would highlight the contribution.

- **Document the Implementation Timeline Carefully**  
  The exact DR adoption dates matter for identification. The paper should include a table listing each state’s DR start year, the source (e.g., Child Welfare Information Gateway), and whether the start was partial (pilot/county) or statewide. This would reassure readers that the treatment indicator is precise and not conflating partial implementations with full reforms.

- **Interpretation of Standardized Effects**  
  Table A.1 is helpful but currently in the appendix. Consider moving the discussion of standardized effect sizes into the main text to clarify that the estimated attenuation (-0.09 SD) is modest relative to the national decline (47%). This would help readers gauge whether DR can plausibly explain most of the observed trend.

- **Address Potential Spillovers or Anticipation**  
  Some states may have anticipated DR adoption or trialed pilot programs before formal adoption. Discuss whether anticipatory effects are likely and whether the treatment variable captures them. If anticipation exists, estimate models with leads to check for pre-trends, and consider coding early pilot years as partial treatment or shifting the treatment window.

- **Clarify Terminology and Mechanism**  
  The abstract and introduction claim that DR “manufactures” declines. For readers less familiar, a brief schematic (e.g., a flow diagram showing screened-in referrals → investigation vs. assessment) would concretely illustrate how the statistical pathway works. Similarly, define “family assessment” more operationally (e.g., no substantiation, no perpetrator). Enhancing clarity helps readers understand the measurement channel.

By addressing the above concerns—especially through additional power, more detailed validation of parallel trends, and richer mechanism checks—the paper could deliver a more definitive and policy-relevant statement about how administrative practices shape malreporting statistics.
